The authors warmly thank Dr. KK Fenrich, Dr. M-C. Amoureux, P. Weber and A. Jaouen for helpful discussions; M. Hocine, C. Meunier, M. Metwaly, S. Bensemmane, J. Bonnardel, the staff of the animal facility at IBDML and the staff of the PicSIL imaging platform at IBDML for technical support. This work was supported by grants from Institut National du Cancer (INCA-DGOS-INSERM6038) to GR, Agence Nationale de la Recherche (ANR JCJC PathoVisu3Dyn), F&#233;d&#233;ration pour la Recherche sur le Cerveau (FRC) to FD, by fellowships from the F&#233;d&#233;ration de la Recherche M&#233;dicale and Canc&#233;ropole PACA to CR.

All experimental procedures were performed in accordance with the French legislation and in compliance with the European Community Council Directive of November 24, 1986 (86/609/EEC) for the care and use of laboratory animals. The research on animals was authorized by the Direction D&#233;partementale des Services V&#233;t&#233;rinaires des Bouches-du-Rh&#244;ne (license D-13-055-21) and approved by the ethical committee of Provence Cote d&#39;Azur n&#176;14 (Project 87-04122012).
1. Spheroids Preparation
<ol>
	<li>Preparation of the agarose-coated Petri dishes
		<ol>
			<li>Mix 1 g of agarose with 100 ml of cell culture medium not supplemented with fetal bovine serum. Use a microwave oven (850 Watts for 40 sec, then 3 x 15 sec; stir the solution in between each microwave session) to boil the solution and to completely dissolve the agarose. Autoclave this 1% agarose solution for 20 min at 120 &#176;C to insure sterility. Note: Take care to completely dissolve the agarose before the autoclave protocol. Inhomogeneity may compromise the formation of spheroids.</li>
			<li>Once retrieved from the autoclave, pour 10 ml of the 1% agarose solution in 100 x 20 mm Petri dishes. Leave the Petri-dishes 20 min at room temperature to allow the 1% agarose solution to solidify.</li>
			<li>Add 10 ml of PBS above the agarose to maintain humidity. Seal the lid of the agarose-coated Petri dishes by wrapping them with parafilm to avoid evaporation. Petri dishes can be stored for up to 2 months at 4 &#176;C if properly humidified by the PBS layer.</li>
		</ol>
	</li>
	<li>Spheroid culture
		<ol>
			<li>In a 75 cm2 flask, culture the glioma cells in their recommended medium as a monolayer.</li>
			<li>Replace the PBS from one of the 1% agarose-coated Petri dish by 1.5 ml of &#34;preconditioned medium&#34; collected from the flask containing the 2D monolayer of glioma cells.</li>
			<li>Remove the medium from the flask containing the 2D monolayer of glioma cells.</li>
			<li>Gently rinse the monolayer with 10 ml of PBS.</li>
			<li>Add 2 ml of 0.05% of a Trypsin/EDTA solution and incubate the flask 4 min at 37 &#176;C. Note: The incubation time may vary according to the cell line used.</li>
			<li>Add 8 ml of culture medium to stop the action of Trypsin, gently flush the cell suspension. Note: Take care not to flush air in the cell suspension as it increases cell death.</li>
			<li>Put 6 ml of the cell suspension in a sterile vial.</li>
			<li>Centrifuge the vial 4 min at 800 rpm.</li>
			<li>Remove the supernatant and gently suspend the cell sediment in 3 ml of culture medium.</li>
			<li>Seed the cell suspension in the prepared agarose-coated Petri dish.</li>
			<li>Put the Petri dish at 37 &#176;C in a 5% CO2 atmosphere for 2 to 3 days until spheroids of desired diameter are formed.</li>
		</ol>
	</li>
</ol>
2. Spheroid and Window Implantation
<ol>
	<li>Preparation of the injection system
		<ol>
			<li>Clean glass capillaries (1 mm in diameter) by sonicating in 70% ethanol for 10 min. Rinse two times with water prior placing inside an incubator until dry.</li>
			<li>Pull several cleaned glass capillaries with a pipette puller in order to prepare a small stock.</li>
			<li>Break the tip of the pulled capillary by scratching the extremity on a piece of tissue paper to obtain a beveled extremity of the desired size: typically an external diameter of 300-350 &#181;m and an internal diameter of 250-300 &#181;m. During this shaping process, control the diameter of the capillary using a macroscope whose ocular is equipped with a graduated mira.</li>
			<li>Connect the non-beveled extremity of the capillary to a 3 way manifold using a piece of plastic tubing whose inner diameter fits the outer diameter of the capillary.</li>
			<li>Using plastic tubing, connect the two other ways of the manifold to a 25 &#181;l microliter syringe and to a 1 ml syringe loaded with histo-compatible mineral oil.</li>
			<li>Adjust the manifold selector to establish a pathway between the microliter syringe and the 1ml syringe. Remove the piston of the microliter syringe and inject mineral oil backward into the microliter syringe until it leaks out by pushing the piston of the 1ml syringe. Replace the piston of the microliter syringe while taking care not to leave air bubbles in the tube.</li>
			<li>Adjust the manifold selector to establish a pathway between the capillary and the 1 ml syringe. Fill the capillary with mineral oil until it leaks out from the tip while taking care not to leave air bubbles in the tube.</li>
			<li>Adjust the manifold selector to establish a connection between the microliter syringe and the capillary. Expel about 10 &#181;l of mineral oil.</li>
			<li>Dip the capillary tip into PBS solution and using the gauge of the microliter syringe, suck in 5&#181;l of PBS in the capillary. Note that the meniscus between oil and PBS is clearly visible.</li>
			<li>Fix the capillary on a 3 axis micromanipulator fitting under the surgery macroscope. This system will be used to target the capillary to the injection site under visual control.</li>
		</ol>
	</li>
	<li>Spheroid implantation
		<ol>
			<li>Lightly sedate the mouse by inhalation of Isoflurane in an induction chamber (1.5% in air during 1 to 1.5 min).</li>
			<li>Anesthetize the animal with an intra-peritoneal injection of a mixture of Ketamine/Xylazine (120 mg/kg, 12 mg/kg). Note that anesthesia often reduces the body temperature of the animal. It is recommended to proceed with surgery in a room at 26 &#176;C and to keep the animal warm with an underlying thermocontrolled heating pad.</li>
			<li>Apply eye ointment to avoid desiccation of the eyes.</li>
			<li>Shave the scalp of the animal.</li>
			<li>Place the animal in a stereotactic frame using ear bars and a mouthpiece.</li>
			<li>Clean the skin with povidone iodine (3% soap, then 10% solution).</li>
			<li>Make a 1 cm long incision longitudinally in the middle of the scalp with a scalpel. Using scissors cut and remove the skin above the parietal bones.</li>
			<li>With a scalpel blade gently remove the periosteum above the skull. Generously apply cyanoacrylate on top of the bone to generate a rough surface for later cement adherence.</li>
			<li>Drill the parietal bone under a surgical macroscope to generate a craniotomy of 4 mm diameter. Generously add ice-cold PBS containing Pencillin (1,000 U/ml) and Streptomicin (1 mg/ml) during the whole procedure to prevent heating. Remove the small bone fragments with forceps and a wet sterile gauze. Take care to drill at least 1mm away from parietal skull sutures to avoid hemorrhages.</li>
			<li>Thin the bone at the border of the craniotomy where the glass window will be sealed. Aim is to ensure later planar positioning of the glass window with maximal contact surface between the brain and the glass. Slowly remove the bone using a forceps and clean the exposed dura-mater with the PBS solution.</li>
			<li>Take a 5 mm diameter round glass coverslip, clean it with alcohol and dry it with tissue paper. Try to use the coverslip as a lid for the craniotomy and confirm that a large flat surface of the brain gets into contact with the glass. If necessary remove the coverslip to further thin the side bones. Proceed until the brain can get squeezed flat if gently applying pressure on the coverslip once in place.</li>
			<li>Clean again the coverslip with alcohol, dry it with tissue paper, and save it apart.</li>
			<li>With a 26 gauge needle make a hole in the dura-mater in the center of the craniotomy yet avoiding main blood vessels. Make sure not to damage the brain parenchyma as the purpose of this step is just to open the dura-mater.</li>
			<li>Gently clean the dura-mater with PBS solution to remove hemorrhagic blood. Cover with a piece of tissue paper while preparing the spheroid injection.</li>
			<li>With the spheroid injection system prepared in step 2.1, suck a round spheroid fitting the capillary inner diameter (approximately 200-250 &#181;m) from the Petri dish prepared in step 1.2. Spheroid should come along with roughly 5 &#181;l culture medium. It should fall down to the tip of the capillarity under its weight.</li>
			<li>Remove the wet tissue paper used to cover the craniotomy and position the animal under the injection system.</li>
			<li>Lower the injection pipette until it touches the hole made in the dura-mater. Then, lower it again by 250 &#181;m. Wait 30 sec.</li>
			<li>Slowly inject the spheroid using the piston of the microliter syringe (2-3 &#181;l) while pumping out the excess liquid with a thin piece of tissue paper. Wait 30 sec and then gently lift the injection pipette by 50 &#181;m toward the surface. Wait again 30 sec and repeat the lifting procedure by steps of 50 &#181;m until the surface. Waiting times avoids extraction of the spheroid that would stick to the pipette.</li>
			<li>Confirm the presence of the spheroid in the brain using a fluorescence macroscope.</li>
			<li>Mix 100-300 &#181;m diameter cross-linked dextran gel beads with PBS solution in a Petri dish. Wait 1min and fish some hydrated beads. Place them on the bone adjacent to the craniotomy.</li>
			<li>Under macroscopic control, choose one bead with a diameter similar to the size of the dura-mater opening. Cut the cross-linked dextran gel bead in two halves using forceps.</li>
			<li>Gently put a cross-linked dextran gel hemi-bead into the injection hole with the convex face toward the spheroid. Take care not to remove the spheroid and press gently downward until the frontier of the concave get into contact with the surrounding dura-mater.</li>
			<li>Put a drop of cyanoacrylate glue on a glass slide; dip the tip of a toothpick into the drop to take a small amount of glue. Quickly seal the edges of the cross-linked dextran gel hemi-bead to the adjacent dura-mater by stamping glue around. Take care to perform fast and accurate movements in order to avoid gluing the cross-linked dextran gel hemi-bead to the toothpick. Avoid excess of glue that can spread and impede if not prevent imaging once dried. Wait 2 min for the glue to dry and then clean the craniotomy and the surrounding bone with PBS solution.</li>
		</ol>
	</li>
	<li>Window implantation
		<ol>
			<li>Put the 5 mm diameter round coverslip above the craniotomy (see 2.2.12). The edges of the coverslip must be on the thinned skull at the exterior of the craniotomy. The coverslip must be in contact with the dura-mater and the thinned bone on the edges. It is very important to have a direct contact between the dura-mater and the glass coverslip otherwise scar tissue may develop and impede optical clarity.</li>
			<li>With a tissue, absorb the PBS on the coverslip edges so that solution does not fully cover the craniotomy when applying a small pressure in the center of the coverslip. This will ensure that bone, glass and brain are glued together on the side of the region of interest.</li>
			<li>Maintain a small pressure at the center of the coverslip with a forceps while gently applying cyanoacrylate at the border between the bone and the coverslip. The glue will spontaneously spread until the interface with PBS solution. Solution will act as a barrier given the hydrophobicity of the glue. Sealing should be effective in less than a minute but take an extreme care not to move the coverslip until it is fixed. This would otherwise result in cyanoacrylate leakage on the dura-mater hence lead to a failure of the surgery.</li>
			<li>In case glue would have spread on top of the glass, remove it using a micro-scalpel blade by doing spiral movements as it may otherwise reduce optical clarity. Watch out not to break the glass coverslip during the procedure due to excessive pressure.</li>
			<li>Consolidate the glass fixation by applying dental cement on the edges of the coverslip toward the adjacent skull. Make sure to cover the whole exposed skull until the scalp. Using extra cement, build up side walls around the coverslip to create the pool required for immersion of the objective. The dental cement will cure in less than 10 min.</li>
		</ol>
	</li>
</ol>
3. Post-operative Care and Preparation for Imaging
<ol>
	<li>Post-operative care
		<ol>
			<li>Remove the mouse from the stereotactic frame, inject Dexamethazon (0.2 mg/kg) and Rimadyl (5 mg/kg) s.c. over the pelvic regions and lay her in a cage with a warm tissue-nest. </li>
			<li>Monitor the animal until the effects of anesthesia have vanished. In general 2 to 3 hr after surgery, mice are fully mobile. Make sure that the animal has an easy access to food and water. Provide the animal with agarose containing glucose (agarose 3%, glucose 3%).</li>
			<li>Monitor the animal weight every day and inject Dexamethazon (0.2 mg/kg) and Rimadyl (5 mg/kg) s.c. for the first 10d after surgery. For ethical considerations, euthanize the mice when loss exceeds 15% of its original weight. Intracranial pressure increases with tumor size leading to motor impairments for the animal. This is tumor cell line dependent and occurs at various delays post-surgery. Special care should be taken to characterize the endpoint of the experiment with the cell line used.</li>
		</ol>
	</li>
	<li>Preparation for imaging
		<ol>
			<li>Lightly sedate the mouse by inhalation of Isoflurane in an induction chamber (1.5% in air for 1 to 1.5 min).</li>
			<li>Anesthetize the animal with an intra-peritoneal injection of a mixture of Ketamine / Xylazine (100 mg/kg, 10 mg/kg). Such an anesthesia typically allows 45 min of observation. To perform longer imaging sessions, mouse is placed under continuous inhalation of Isoflurane in air (0.25-0.75%).</li>
			<li>Apply eye ointment to avoid desiccation of the eyes.</li>
			<li>Put the animal on a stereotactic frame and block the skull with the earbars.</li>
			<li>To visualize the blood vessels, a fluorescent dye can be injected intravenously.</li>
			<li>If the window appears dirty, it can be cleaned by gently removing the debris with a thin blade and the corner of a tissue. Do not use alcohol to clean the window as it is not always compatible with dental cement and it can cool the brain below the window.</li>
		</ol>
	</li>
</ol>

<ol>
	<li>DeAngelis, L. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Brain+tumors.">Brain tumors.</a> N Engl J Med. 344, 114-123 (2001).</li><li>Ricard, D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Primary+brain+tumours+in+adults.">Primary brain tumours in adults.</a> Lancet. 379, 1984-1996 (2012).</li><li>Prados, M. D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Phase+III+randomized+study+of+radiotherapy+plus+procarbazine,+lomustine,+and+vincristine+with+or+without+BUdR+for+treatment+of+anaplastic+astrocytoma:+final+report+of+RTOG+9404.">Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404.</a> Int J Radiat Oncol Biol Phys. 58, 1147-1152 (2004).</li><li>Piao, Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Glioblastoma+resistance+to+anti-VEGF+therapy+is+associated+with+myeloid+cell+infiltration,+stem+cell+accumulation,+and+a+mesenchymal+phenotype.">Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype.</a> Neuro Oncol. 14, 1379-1392 (2012).</li><li>Zhai, H., Heppner, F. L., Tsirka, S. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Microglia/macrophages+promote+glioma+progression.">Microglia/macrophages promote glioma progression.</a> Glia. 59, 472-485 (2011).</li><li>Studwell, A. J., Kotton, D. N. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+shift+from+cell+cultures+to+creatures:+in+vivo+imaging+of+small+animals+in+experimental+regenerative+medicine.">A shift from cell cultures to creatures: in vivo imaging of small animals in experimental regenerative medicine.</a> Mol Ther. 19, 1933-1941 (2011).</li><li>Ustione, A., Piston, D. W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+simple+introduction+to+multiphoton+microscopy.">A simple introduction to multiphoton microscopy.</a> J Microsc. 243, 221-226 (2011).</li><li>Ricard, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Short-term+effects+of+synchrotron+irradiation+on+vasculature+and+tissue+in+healthy+mouse+brain.">Short-term effects of synchrotron irradiation on vasculature and tissue in healthy mouse brain.</a> J Synchrotron Radiat. 16, 477-483 (2009).</li><li>von Baumgarten, L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Bevacizumab+has+differential+and+dose-dependent+effects+on+glioma+blood+vessels+and+tumor+cells.">Bevacizumab has differential and dose-dependent effects on glioma blood vessels and tumor cells.</a> Clin Cancer Res. 17, 6192-6205 (2011).</li><li>Helmchen, F., Denk, W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Deep+tissue+two-photon+microscopy.">Deep tissue two-photon microscopy.</a> Nat Methods. 2, 932-940 (2005).</li><li>Mostany, R., Portera-Cailliau, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+craniotomy+surgery+procedure+for+chronic+brain+imaging.">A craniotomy surgery procedure for chronic brain imaging.</a> J Vis Exp. , 680 (2008).</li><li>Lathia, J. D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Direct+in+vivo+evidence+for+tumor+propagation+by+glioblastoma+cancer+stem+cells.">Direct in vivo evidence for tumor propagation by glioblastoma cancer stem cells.</a> PLoS One. 6, (2011).</li><li>Madden, K. S., Zettel, M. L., Majewska, A. K., Brown, E. B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Brain+tumor+imaging:+live+imaging+of+glioma+by+two-photon+microscopy.">Brain tumor imaging: live imaging of glioma by two-photon microscopy.</a> Cold Spring Harb Protoc. 2013, (2013).</li><li>Winkler, F., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Imaging+glioma+cell+invasion+in+vivo+reveals+mechanisms+of+dissemination+and+peritumoral+angiogenesis.">Imaging glioma cell invasion in vivo reveals mechanisms of dissemination and peritumoral angiogenesis.</a> Glia. 57, 1306-1315 (2009).</li><li>Newcomb, E., Zagzag, D., Van Meir, E. G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Ch.+12.">Ch. 12.</a> CNS Cancer, Cancer Drug Discovery and Development. , 227-241 (2009).</li><li>Ulrich, T. A., de Juan Pardo, E. M., Kumar, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+mechanical+rigidity+of+the+extracellular+matrix+regulates+the+structure,+motility,+and+proliferation+of+glioma+cells.">The mechanical rigidity of the extracellular matrix regulates the structure, motility, and proliferation of glioma cells.</a> Cancer Res. 69, 4167-4174 (2009).</li></ol>

The authors declare that they have no competing financial interests.

This approach allows the use of optical imaging methods to monitor over days and weeks the growth of an orthotopically implanted glioma. The same animal can subsequently be subjected to virtually any brain imaging modality during the course of the pathology; yet the two-photon microscopy specific preparation offers the unique opportunity to achieve subcellular resolution inside the brain of the living animal. Our protocol presents the advantage to enforce the tumor growth into the cerebral parenchyma rather than extra-du...

Glioblastoma multiforme appears as the most aggressive form of brain tumor in adults with a median survival of 12 months and a 5-years survival rate of 5%. Clinical management relies on surgery, radiotherapy and chemotherapy often used in combination. However, the effects of these treatments remain palliative1-3.
Up to now, most of neuro-oncology studies rely on techniques that are only able to provide a static view and performed on large cohorts of tumor bearing animals sacrificed at different time-points (see for example4,5). The recent development of follow-up methods based on intravital imaging allows studying glioma growth and the interactions between tumor cells and their pathophysiological microenvironment on the same animal over time. This opens the way to exclusive piece of information that was so far unachievable6. Transgenic animals expressing fluorescent tags in cells of interest may be used to study specific interactions between tumor cells and e.g. neurons in this paper.
Over the past decade, intravital two-photon microscopy7 has become a gold standard in fundamental neuro-oncology studies and preclinical trials8,9 for its ability to perform deep intravital observation of mouse brain (&#62;500 &#181;m below the dura-mater) with a micrometric spatial resolution10. Using intravital two-photon microscopy with orthotopical animal models implanted with a chronic cranial window11, it is possible to follow the tumor progression over time on the same mouse9,12.
One of the major drawbacks of these previously published animal models is however that they do not mimic the physical constraints that govern tumor growth as the dura-mater is not sealed after the injection of the cell suspension9,13,14. Glioma cells may leak in the extradural space transforming an orthotopic glioma model into a heterotopic one.
The animal model presented here consists in the injection of a spheroid of fluorescent glioma cells in the cerebral cortex at a depth of 200 &#181;m followed by the sealing of the dura-mater with a cross-linked dextran gel hemi-bead and histo-compatible glue. The tumor growth is then restricted to the brain parenchyma that maintains pathophysiological physical constraints. A chronic glass window implanted above the tumor allows an easy optical access for intravital two-photon microscopy. Using transgenic animals expressing fluorescent tags in cells of interest it is possible to perform a follow-up of the glioma growth over time and to study its interaction with its microenvironment (here with neurons and vasculature highlighted with fluorescent dextrans).

<table border="0" cellpadding="0" cellspacing="0" width="1337">
	<colgroup>
		<col />
		<col />
		<col />
		<col />
	</colgroup>
	<tbody>
		<tr height="38">
			<td height="38" style="height:38px;width:425px;">Drill</td>
			<td style="width:383px;">Dremel (Germany)</td>
			<td style="width:156px;">398</td>
			<td style="width:375px;">any high quality surgical bone drill would suffice</td>
		</tr>
		<tr height="38">
			<td height="38" style="height:38px;width:425px;">Drill burr (#1/4 Carbide Round Burr)</td>
			<td style="width:383px;">World Precision Instruments (USA)</td>
			<td>501860 (#1/4)</td>
			<td>also sold by Harvard Apparatus</td>
		</tr>
		<tr height="38">
			<td height="38" style="height:38px;">Tissue scissors</td>
			<td style="width:383px;">World Precision Instruments (USA)</td>
			<td>14395</td>
			<td style="width:375px;"></td>
		</tr>
		<tr height="38">
			<td height="38" style="height:38px;">Dumont tweezers M5S</td>
			<td style="width:383px;">World Precision Instruments (USA)</td>
			<td>501764</td>
			<td></td>
		</tr>
		<tr height="38">
			<td height="38" style="height:38px;">Dental cement</td>
			<td>GACD (USA)</td>
			<td>12-565 &#38; 12-568</td>
			<td></td>
		</tr>
		<tr height="38">
			<td height="38" style="height:38px;">Cyanoacrylate</td>
			<td>Eleco-EFD (France)</td>
			<td>Cyanolit 201</td>
			<td></td>
		</tr>
		<tr height="38">
			<td height="38" style="height:38px;">Glass capillaries without filament</td>
			<td>Clark Electromedical Instruments (UK)</td>
			<td>GC100-15</td>
			<td></td>
		</tr>
		<tr height="38">
			<td height="38" style="height:38px;">Microliter syringe (25 &#181;l)</td>
			<td>Hamilton (USA)</td>
			<td>702</td>
			<td></td>
		</tr>
		<tr height="38">
			<td height="38" style="height:38px;">Micromanipulator</td>
			<td style="width:383px;">World Precision Instruments (USA)</td>
			<td>Kite-R</td>
			<td></td>
		</tr>
		<tr height="38">
			<td height="38" style="height:38px;">T derivation (3-way stopcock - Luer lock)</td>
			<td style="width:383px;">World Precision Instruments (USA)</td>
			<td>14035-10</td>
			<td></td>
		</tr>
		<tr height="38">
			<td height="38" style="height:38px;">Stereotactic frame (mouse adaptor)</td>
			<td style="width:383px;">World Precision Instruments (USA)</td>
			<td>502063</td>
			<td></td>
		</tr>
		<tr height="38">
			<td height="38" style="height:38px;">Glass coverslips</td>
			<td>Warner Instruments (USA)</td>
			<td>CS-5R (64-0700)</td>
			<td></td>
		</tr>
		<tr height="38">
			<td height="38" style="height:38px;">Cross-linked dextran gel (Sephadex) G50 Coarse 100-300 &#181;m beads</td>
			<td>Available from various suppliers including Sigma (Germany)</td>
			<td></td>
			<td></td>
		</tr>
		<tr height="38">
			<td height="38" style="height:38px;">Eye ointment</td>
			<td>TVM (France)</td>
			<td>Ocry-gel</td>
			<td></td>
		</tr>
		<tr height="38">
			<td height="38" style="height:38px;">Fluorescence macroscope</td>
			<td>Leica MZFLIII (Germany)</td>
			<td></td>
			<td>also sold by other companies</td>
		</tr>
		<tr height="38">
			<td height="38" style="height:38px;">Two-photon microscope</td>
			<td>Zeiss LSM 7MP (Germany)</td>
			<td></td>
			<td>also sold by other companies (Nikon, &#8230;)</td>
		</tr>
		<tr height="38">
			<td height="38" style="height:38px;">Infrared tunable femtosecond laser (Ma&#239;-Ta&#239;)</td>
			<td>Spectra Physics (USA)</td>
			<td></td>
			<td>also sold by other companies</td>
		</tr>
	</tbody>
</table>

an orthotopic glioblastoma mouse model maintaining brain parenchymal physical constraints and suitable for intravital two-photon microscopy

Glioblastoma multiforme (GBM) is the most aggressive form of brain tumors with no curative treatments available to date.
Murine models of this pathology rely on the injection of a suspension of glioma cells into the brain parenchyma following incision of the dura-mater. Whereas the cells have to be injected superficially to be accessible to intravital two-photon microscopy, superficial injections fail to recapitulate the physiopathological conditions. Indeed, escaping through the injection tract most tumor cells reach the extra-dural space where they expand abnormally fast in absence of mechanical constraints from the parenchyma.
Our improvements consist not only in focally implanting a glioma spheroid rather than injecting a suspension of glioma cells in the superficial layers of the cerebral cortex but also in clogging the injection site by a cross-linked dextran gel hemi-bead that is glued to the surrounding parenchyma and sealed to dura-mater with cyanoacrylate. Altogether these measures enforce the physiological expansion and infiltration of the tumor cells inside the brain parenchyma. Craniotomy was finally closed with a glass window cemented to the skull to allow chronic imaging over weeks in absence of scar tissue development.
Taking advantage of fluorescent transgenic animals grafted with fluorescent tumor cells we have shown that the dynamics of interactions occurring between glioma cells, neurons (e.g. Thy1-CFP mice) and vasculature (highlighted by an intravenous injection of a fluorescent dye) can be visualized by intravital two-photon microscopy during the progression of the disease.
The possibility to image a tumor at microscopic resolution in a minimally compromised cerebral environment represents an improvement of current GBM animal models which should benefit the field of neuro-oncology and drug testing.

Once the surgical protocol is performed (Figure 1), animals can be observed by means of fluorescent microscopy over weeks until sacrifice. An inflammatory reaction may be observed after the surgery that disappears within one or two weeks. Tumor growth can be observed by various microscopy techniques including fluorescent macroscopy and two-photon microscopy (Figure 2). Example images depicted here were realized on a fluorescence macroscope and a two-photon microscope coupled to a femtose...

Watch this Scientific Journal Video about An Orthotopic Glioblastoma Mouse Model Maintaining Brain Parenchymal Physical Constraints and Suitable for Intravital Two-photon Microscopy at JoVE.com

An Orthotopic Glioblastoma Mouse Model Maintaining Brain Parenchymal Physical Constraints and Suitable for Intravital Two-photon Microscopy

We have established a cortical orthotopic glioblastoma model in mice for intravital two-photon microscopy that recapitulates the biophysical constraints normally at play during the growth of the tumor. A chronic glass window replacing the skull above the tumor enables the follow-up of the tumor progression over time by two-photon microscopy.

Glioblastoma multiforme (GBM) is the most aggressive form of brain tumors with no curative treatments available to date.
Murine models of this pathology ...

an-orthotopic-glioblastoma-mouse-model-maintaining-brain-parenchymal

Research

JoVE Journal

Medicine

19.6K Views.  Aix Marseille University.  Мы создали корковой ортотопической модели глиобластомы у мышей для прижизненной двухфотонного микроскопии, что повторяет биофизических ограничений обычно при игре в процессе роста опухоли. Хронический стекла замена череп выше опухоли позволяет наблюдени?...

Video: An Orthotopic Glioblastoma Mouse Model Maintaining Brain Parenchymal Physical Constraints and Suitable for Intravital Two-photon Microscopy

An Orthotopic Model of Murine Bladder Cancer

In this straightforward procedure, bladder tumors are established in female C57 mice through the use of catheterization, local cauterization, and subsequent cell adhesion. After their bladders are transurethrally catheterized and drained, animals are again catheterized to permit insertion of a platinum wire into bladders without damaging the urethra or bladder. The catheters are made of Teflon to serve as an insulator for the wire, which will conduct electrical current into the bladder to create a burn injury. An electrocautery unit is used to deliver 2.5W to the exposed end of the wire, burning away extracellular layers and providing attachment sites for carcinoma cells that are delivered in suspension to the bladder through a subsequent catheterization. Cells remain in the bladder for 90 minutes, after which the catheters are removed and the bladders allowed to drain naturally. The development of tumor is monitored via ultrasound. Specific attention is paid to the catheterization technique in the accompanying video.

Bladder tumors are established in female mice in a minimally invasive fashion through catheterization, local cauterization, and subsequent adhesion of carcinoma cells to the burn sites.

In this straightforward procedure, bladder tumors are established in female C57 mice through the use of catheterization, local cauterization, and ...

Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma

Loco-regional invasion of head and neck cancer is linked to metastatic risk and presents a difficult challenge in designing and implementing patient management strategies. Orthotopic mouse models of oral cancer have been developed to facilitate the study of factors that impact invasion and serve as model system for evaluating anti-tumor therapeutics. In these systems, visualization of disseminated tumor cells within oral cavity tissues has typically been conducted by either conventional histology or with in vivo bioluminescent methods. A primary drawback of these techniques is the inherent inability to accurately visualize and quantify early tumor cell invasion arising from the primary site in three dimensions. Here we describe a protocol that combines an established model for squamous cell carcinoma of the tongue (SCOT) with two-photon imaging to allow multi-vectorial visualization of lingual tumor spread. The OSC-19 head and neck tumor cell line was stably engineered to express the F-actin binding peptide LifeAct fused to the mCherry fluorescent protein (LifeAct-mCherry). Fox1nu/nu mice injected with these cells reliably form tumors that allow the tongue to be visualized by ex-vivo application of two-photon microscopy. This technique allows for the orthotopic visualization of the tumor mass and locally invading cells in excised tongues without disruption of the regional tumor microenvironment. In addition, this system allows for the quantification of tumor cell invasion by calculating distances that invaded cells move from the primary tumor site. Overall this procedure provides an enhanced model system for analyzing factors that contribute to SCOT invasion and therapeutic treatments tailored to prevent local invasion and distant metastatic spread. This method also has the potential to be ultimately combined with other imaging modalities in an in vivo setting.

A comprehensive overview of the techniques involved in generating a mouse model of oral cancer and quantitative monitoring of tumor invasion within the tongue through multi-photon microscopy of labeled cells is presented. This system can serve as a useful platform for the molecular assessment and drug efficacy of anti-invasive compounds.

Loco-regional invasion of head and neck cancer is linked to metastatic risk and presents a difficult challenge in designing and implementing patient ...

Combination Radiotherapy in an Orthotopic Mouse Brain Tumor Model

Glioblastoma multiforme (GBM) are the most common and aggressive adult primary brain tumors1. In recent years there has been substantial progress in the understanding of the mechanics of tumor invasion, and direct intracerebral inoculation of tumor provides the opportunity of observing the invasive process in a physiologically appropriate environment2. As far as human brain tumors are concerned, the orthotopic models currently available are established either by stereotaxic injection of cell suspensions or implantation of a solid piece of tumor through a complicated craniotomy procedure3. In our technique we harvest cells from tissue culture to create a cell suspension used to implant directly into the brain. The duration of the surgery is approximately 30 minutes, and as the mouse needs to be in a constant surgical plane, an injectable anesthetic is used. The mouse is placed in a stereotaxic jig made by Stoetling (figure 1). After the surgical area is cleaned and prepared, an incision is made; and the bregma is located to determine the location of the craniotomy. The location of the craniotomy is 2 mm to the right and 1 mm rostral to the bregma. The depth is 3 mm from the surface of the skull, and cells are injected at a rate of 2 &mu;l every 2 minutes. The skin is sutured with 5-0 PDS, and the mouse is allowed to wake up on a heating pad. From our experience, depending on the cell line, treatment can take place from 7-10 days after surgery. Drug delivery is dependent on the drug composition. For radiation treatment the mice are anesthetized, and put into a custom made jig. Lead covers the mouse's body and exposes only the brain of the mouse. The study of tumorigenesis and the evaluation of new therapies for GBM require accurate and reproducible brain tumor animal models. Thus we use this orthotopic brain model to study the interaction of the microenvironment of the brain and the tumor, to test the effectiveness of different therapeutic agents with and without radiation.

The purpose of this article is to describe the use of an orthotopic glioblastoma model for chemoradiation studies. This article will go though cell processing, implanting, and radiotherapy of the mouse using an intracranial model.

Glioblastoma multiforme (GBM) are the most common and aggressive adult primary brain tumors1. In recent years there has been substantial progress in the ...

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Several types of animal models of human thyroid carcinomas have been established, including subcutaneous xenograft and orthotopic implantation of cancer cells into immunodeficient mice. Subcutaneous xenograft models have been valuable for preclinical screening and evaluation of new therapeutic treatments. There are a number of advantages to using a subcutaneous model; 1) rapid, 2) reproducible, and 3) tumor establishment, growth, and response to therapeutic agents may be monitored by visual inspection. However, substantial evidence has shed light on the short-comings of subcutaneous xenograft models1-3. For instance, medicinal treatments demonstrating curative properties in subcutaneous xenograft models often have no notable impact on the human disease. The microenvironment of the site of xenographic transplantation or injection lies at the heart of this dissimilarity.
Orthotopic tumor xenograft models provide a more biologically relevant context in which to study the disease. The advantages of implanting diseased cells or tissue into their anatomical origin equivalent within a host animal includes a suitable site for tumor-host interactions, development of disease-related metastases and the ability to examine site-specific influence on investigational therapeutic remedies. Therefore, orthotopic xenograft models harbor far more clinical value because they closely reproduce human disease. For these reasons, a number of groups have taken advantage of an orthotopic thyroid cancer model as a research tool4-7.
Here, we describe an approach that establishes an orthotopic model for the study of anaplastic thyroid carcinoma (ATC), which is highly invasive, resists treatment, and is virtually fatal in all diagnosed patients. Cultured ATC cells are prepared as a dissociated cellular suspension in a solution containing a basement membrane matrix. A small volume is slowly injected into the right thyroid gland. Overall appearance and health of the mice are monitored to ensure minimal post-operative complications and to gauge pathological penetrance of the cancer. Mice are sacrificed at 4 weeks, and tissue is collected for histological analysis. Animals may be taken at later time-points to examine more advance progression of the disease. Production of this orthotopic mouse model establishes a platform that accomplishes two objectives: 1) further our understanding of ATC pathology, and 2) screen current and future therapeutic agents for efficacy in combating ATC.

Generation of an orthotopic mouse model of anaplastic thyroid carcinoma is described here. This technique employs surgical placement of human anaplastic thyroid cancer cells into the thyroid of immunodeficient mice, thus creating a more clinically relevant setting to study disease progression as well as screen innovative therapeutic interventions.

Several types of animal models of human thyroid carcinomas have been established, including subcutaneous xenograft and orthotopic implantation of cancer ...

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Bladder cancer is the second most common cancer of the urogenital tract and novel therapeutic approaches that can reduce recurrence and progression are needed. The tumor microenvironment can significantly influence tumor development and therapy response. It is therefore often desirable to grow tumor cells in the organ from which they originated. This protocol describes an orthotopic model of bladder cancer, in which MB49 murine bladder carcinoma cells are instilled into the bladder via catheterization. Successful tumor cell implantation in this model requires disruption of the protective glycosaminoglycan layer, which can be accomplished by physical or chemical means. In our protocol the bladder is treated with trypsin prior to cell instillation. Catheterization of the bladder can also be used to deliver therapeutics once the tumors are established. This protocol describes the delivery of an adenoviral construct that expresses a luciferase reporter gene. While our protocol has been optimized for short-term studies and focuses on gene delivery, the methodology of mouse bladder catheterization has broad applications.

Implantation of cancer cells into the organ of origin can serve as a useful preclinical model to evaluate novel therapies. MB49 bladder carcinoma cells can be grown within the bladder following intravesical instillation. This protocol demonstrates catheterization of the mouse bladder for the purpose of tumor implantation and adenoviral delivery.

Bladder cancer is the second most common cancer of the urogenital tract and novel therapeutic approaches that can reduce recurrence and progression are ...

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Our laboratory has developed a novel orthotopic implantation model of human prostate cancer (PCa). As PCa death is not due to the primary tumor, but rather the formation of distinct metastasis, the ability to effectively model this progression pre-clinically is of high value. In this model, cells are directly implanted into the ventral lobe of the prostate in Balb/c athymic mice, and allowed to progress for 4-6 weeks. At experiment termination, several distinct endpoints can be measured, such as size and molecular characterization of the primary tumor, the presence and quantification of circulating tumor cells in the blood and bone marrow, and formation of metastasis to the lung. In addition to a variety of endpoints, this model provides a picture of a cells ability to invade and escape the primary organ, enter and survive in the circulatory system, and implant and grow in a secondary site. This model has been used effectively to measure metastatic response to both changes in protein expression as well as to response to small molecule therapeutics, in a short turnaround time.

This orthotopic model of human prostate cancer allows for quantification of tumor size, circulating tumor cells, and formation of distinct metastasis to the lung. As cells must escape the primary organ, enter the blood stream, and implant into a secondary site, this model effectively recapitulates the scenario in humans.

Our laboratory has developed a novel orthotopic implantation model of  human prostate cancer (PCa). As PCa death is not due to the primary tumor, but  ...

Acute Brain Trauma in Mice Followed By Longitudinal Two-photon Imaging

Although acute brain trauma often results from head damage in different accidents and affects a substantial fraction of the population, there is no effective treatment for it yet. Limitations of currently used animal models impede understanding of the pathology mechanism. Multiphoton microscopy allows studying cells and tissues within intact animal brains longitudinally under physiological and pathological conditions. Here, we describe two models of acute brain injury studied by means of two-photon imaging of brain cell behavior under posttraumatic conditions. A selected brain region is injured with a sharp needle to produce a trauma of a controlled width and depth in the brain parenchyma. Our method uses stereotaxic prick with a syringe needle, which can be combined with simultaneous drug application. We propose that this method can be used as an advanced tool to study cellular mechanisms of pathophysiological consequences of acute trauma in mammalian brain in vivo. In this video, we combine acute brain injury with two preparations: cranial window and skull thinning. We also discuss advantages and limitations of both preparations for multisession imaging of brain regeneration after trauma.

Acute brain trauma is a severe injury that has no adequate treatment to date. Multiphoton microscopy allows studying longitudinally the process of acute brain trauma development and probing therapeutical strategies in rodents. Two models of acute brain trauma studied with in vivo two-photon imaging of brain are demonstrated in this protocol.

Although acute brain trauma often results from head damage in different accidents and affects a substantial fraction of the population, there is no ...

Bioluminescence Imaging of an Immunocompetent Animal Model for Glioblastoma

In contrast to commonly reported human glioma xenograft animal models, GL261 murine glioma xenografts recapitulate nearly all relevant clinical and histopathologic features of the human disease. When GL261 cells are implanted intracranially in syngeneic C57BL/6 mice, the model has the added advantage of maintaining an intact immune microenvironment. Stable expression of luciferase in GL261 cells allows non-invasive cost effective bioluminescence monitoring of intracranial tumor growth. We have recently demonstrated that luciferase expression in GL261 cells does not affect the tumor growth properties, tumor cell immunomodulatory cytokine expression, infiltration of immune cells into the tumor, or overall survival of animals bearing the intracranial tumor. Therefore, it appears that the GL261 luciferase glioma model can be useful in the study of novel chemotherapeutic and immunotherapeutic modalities. Here we report the technique for generating stable luciferase expression in GL261 cells and how to study the in vitro and in vivo growth of the tumor cells by bioluminescence imaging.

GL261 glioma cells provide a useful immunocompetent animal model of glioblastoma. The goals of this protocol are to demonstrate proper techniques for monitoring intracranial tumor growth using in vivo bioluminescence imaging, and to verify the utility of luciferase-modified GL261 cells for studying tumor immunology and immunotherapeutic approaches for treating glioblastoma.

In contrast to commonly reported human glioma xenograft animal models, GL261 murine glioma xenografts recapitulate nearly all relevant clinical and ...

An Orthotopic Mouse Model of Spontaneous Breast Cancer Metastasis

Metastasis is the primary cause of mortality of breast cancer patients. The mechanism underlying cancer cell metastasis, including breast cancer metastasis, is largely unknown and is a focus in cancer research. Various breast cancer spontaneous metastasis mouse models have been established. Here, we report a simplified procedure to establish orthotopic transplanted breast cancer primary tumor and resultant spontaneous metastasis that mimic human breast cancer metastasis. Combined with the bioluminescence live tumor imaging, this mouse model allows tumor growth and progression kinetics to be monitored and quantified. In this model, a low dose (1 x 104 cells) of 4T1-Luc breast cancer cells was injected into BALB/c mouse mammary fat pad using a tuberculin syringe. Mice were injected with luciferin and imaged at various time points using a bioluminescent imaging system. When the primary tumors grew to the size limit as in the IACUC-approved protocol (approximately 30 days), mice were anesthetized under constant flow of 2% isoflurane and oxygen. The tumor area was sterilized with 70% ethanol. The mouse skin around the tumor was excised to expose the tumor which was removed with a pair of sterile scissors. Removal of the primary tumor extends the survival of the 4T-1 tumor-bearing mice for one month. The mice were then repeatedly imaged for metastatic tumor spreading to distant organs. Therapeutic agents can be administered to suppress tumor metastasis at this point. This model is simple and yet sensitive in quantifying breast cancer cell growth in the primary site and progression kinetics to distant organs, and thus is an excellent model for studying breast cancer growth and progression, and for testing anti-metastasis therapeutic and immunotherapeutic agents in vivo.

An orthotopic breast cancer primary tumor model and surgical removal of primary tumor to extend mouse life to generate spontaneous metastasis are described. The tumor growth and progression are monitored and quantified by luciferase fluorescence imaging.

Metastasis is the primary cause of mortality of breast cancer patients. The mechanism underlying cancer cell metastasis, including breast cancer ...

Intravital Microscopy and Thrombus Induction in the Earlobe of a Hairless Mouse

Thrombotic complications of vascular diseases are one leading cause of morbidity and mortality in industrial nations. Due to the complex interactions between cellular and non-cellular blood components during thrombus formation, reliable studies of the physiology and pathophysiology of thrombosis can only be performed in vivo. Therefore, this article presents an ear model in hairless mice and focuses on the in vivo analysis of microcirculation, thrombus formation, and thrombus evolution. By using intravital fluorescence microscopy and the intravenous (iv) application of the respective fluorescent dyes, a repetitive analysis of microcirculation in the auricle can easily be performed, without the need for surgical preparation. Furthermore, this model can be adapted for in vivo studies of different issues, including wound healing, reperfusion injury, or angiogenesis. In summary, the ear of hairless mice is an ideal model for the in vivo study of skin microcirculation in physiological or pathophysiological conditions and for the evaluation of its reaction to different systemic or topical treatments.

The ear model of the hairless SKH1-Hrhr mouse enables intravital fluorescence microscopy of microcirculation and phototoxic thrombus induction without prior surgical preparation in the examined microvascular bed. Therefore, the ear of the hairless mouse is an excellent in vivo model to study the complex interactions during microvascular thrombus formation, thrombus evolution, and thrombolysis.

Thrombotic complications of vascular diseases are one leading cause of morbidity and mortality in industrial nations. Due to the complex interactions ...